Rigel Pharma (RIGL) Tops Q1 EPS by 63c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.55 -2.3%
Revenue Growth %: +15.2%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.2%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of $0.63. Revenue for the quarter came in at $53.33 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: We Make A Market Buying Older Bonds
- NY Fed survey shows rising unemployment fears, mixed financial outlook
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
